Dr. Regillo is currently the Director of the Retina Service of Wills Eye Institute, Professor of Ophthalmology at Thomas Jefferson University School of Medicine, and Principle Investigator of several major international clinical trials investigating new forms of treatment for macular degeneration, diabetic retinopathy, and a variety of other retinal conditions. He is the founder and former Director of the Wills Eye Clinical Retina Research Unit, prior Chairman of the Wills Eye Institutional Review Board and prior Chairman of the American Academy’s Basic and Clinical Science Course (BCSC) Retina Section committee. He is the former Wills Retina Fellowship Program Director.
He has authored over 100 publications along with over 20 book chapters and five major books. He has been an investigator on numerous major clinical trials, developing new treatments for retinal disorders such as macular degeneration and diabetic retinopathy. He lectures worldwide and has served on the scientific editorial board for the American Journal of Ophthalmology, Review of Ophthalmology, Current Opinion in Ophthalmology, Yearbook of Ophthalmology, Retinal Physician, and Retina Today. He is a recipient of the American Academy of Ophthalmology Achievement Award, Senior Achievement Award, and Secretariat Award. He also has been listed multiple times through the years as a retina “Top Doc” in the Philadelphia Magazine.